Diabetes Drug Acarbose May Calm Severe Allergies By Reshaping Gut Bacteria
Based on: Acarbose redirects gut microbiome utilization of dietary carbohydrates to suppress anaphylaxis in mice.
In mice, the diabetes drug acarbose changed how gut bacteria use carbs, boosting a microbe that produces succinate. That succinate then blocked the mast cell reactions behind severe allergic shock. A look at human records found people taking similar drugs had fewer anaphylaxis cases.
Key Insight
This study hints that gut bacteria metabolites like succinate may shape allergic responses.
Original Paper
Yakabe K, Inoue Y, Yanagisawa Y, Imai S, Suwa S, Ando M, Wu Y, Kurokawa R, Tanakorn S, Haneda T, Miki T, Ito M, Hirayama A, Kurashima Y, Fukuda S, Hase K, Suda W, Takeyama H, Hori S, Kim YG
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.